Yi Tong

447 total citations
9 papers, 162 citations indexed

About

Yi Tong is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yi Tong has authored 9 papers receiving a total of 162 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Yi Tong's work include Cancer therapeutics and mechanisms (4 papers), Lung Cancer Treatments and Mutations (4 papers) and HER2/EGFR in Cancer Research (2 papers). Yi Tong is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Lung Cancer Treatments and Mutations (4 papers) and HER2/EGFR in Cancer Research (2 papers). Yi Tong collaborates with scholars based in China and Canada. Yi Tong's co-authors include Zhenjiang Zhao, Yufang Xu, Honglin Li, Hua Xie, Deheng Sun, Gang Zou, Jian Ding, Linjiang Tong, Li Zhu and Tao Zhang and has published in prestigious journals such as Journal of Medicinal Chemistry, Organic Letters and Separation and Purification Technology.

In The Last Decade

Yi Tong

9 papers receiving 158 citations

Peers

Yi Tong

MB

OC

PRM

ONCOL

GENET

Eman F. Sanad Egypt

Melinda Broward United States

Savita Ubhayakar United States

Lakshminarayana Vogeti United States

Jitendra K. Mishra India

Berta López Spain

Francesco Marchetti Italy

Bryan E. Welm United States

Erik B. Faber United States

Suzannah J. Harnor United Kingdom

Eman F. Sanad Egypt

Yi Tong

170 ×1.9

MB

41 ×0.6

OC

24 ×0.4

PRM

31 ×0.7

ONCOL

4 ×0.4

GENET

Citations per year, relative to Yi Tong Yi Tong (= 1×) peers Eman F. Sanad

Countries citing papers authored by Yi Tong

Since Specialization

Citations

This map shows the geographic impact of Yi Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Tong more than expected).

Fields of papers citing papers by Yi Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Tong. The network helps show where Yi Tong may publish in the future.

Co-authorship network of co-authors of Yi Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Tong. A scholar is included among the top collaborators of Yi Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Tong. Yi Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tong, Yi, et al.. (2022). Nickel-Catalyzed, Manganese-Assisted Denitrogenative Cross-Electrophile-Coupling of Benzotriazinones with Alkyl Halides for ortho-Alkylated Benzamides. Organic Letters. 24(31). 5741–5745. 21 indexed citations

2.

Zhang, Tao, Shiliang Li, Linjiang Tong, et al.. (2019). Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR^{L858R/T790M/C797S}. ACS Medicinal Chemistry Letters. 10(6). 869–873. 52 indexed citations

3.

Li, Yan, et al.. (2019). Equilibrium and kinetic differences of XOS2-XOS7 in xylo-oligosaccharides and their effects on the design of simulated moving bed purification process. Separation and Purification Technology. 215. 360–367. 10 indexed citations

4.

Tong, Yi, et al.. (2018). Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats. Frontiers in Pharmacology. 9. 1032–1032. 5 indexed citations

5.

Hao, Yong‐Jia, Jiankun Lyu, Rong Qu, et al.. (2018). Design, Synthesis, and Biological Evaluation of Pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation. Journal of Medicinal Chemistry. 61(13). 5609–5622. 28 indexed citations

6.

Hu, Xiu‐Qin, Yi Tong, Linjiang Tong, et al.. (2017). Design, Synthesis, and Evaluation of Ribose-Modified Anilinopyrimidine Derivatives as EGFR Tyrosine Kinase Inhibitors. Frontiers in Chemistry. 5. 101–101. 3 indexed citations

7.

Tong, Yi, et al.. (2016). TRPA1 and TRPM8 Receptors May Promote Local Vasodilation that Aggravates Oxaliplatin-Induced Peripheral Neuropathy Amenable to 17β-Estradiol Treatment. Current Neurovascular Research. 13(4). 309–317. 11 indexed citations

8.

Hao, Yong‐Jia, Xia Wang, Tao Zhang, et al.. (2016). Discovery and Structural Optimization of N5-Substituted 6,7-Dioxo-6,7-dihydropteridines as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation. Journal of Medicinal Chemistry. 59(15). 7111–7124. 22 indexed citations

9.

Li, Shiliang, Yi Tong, Jiawei Wang, et al.. (2016). Structure-based design of potent human dihydroorotate dehydrogenase inhibitors as anticancer agents. MedChemComm. 7(7). 1441–1448. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact